Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Sci Food Agric ; 101(2): 573-581, 2021 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-32673411

RESUMEN

BACKGROUND: Caffeine has an anti-obesity effect, although chronic excessive caffeine consumption also causes caffeinism, which is marked by increased anxiety or depression, amongst other symptoms. The present study aimed to investigate whether the addition of flavonoids such as astilbin can reduce the caffeine dose needed to inhibit obesity. RESULTS: ICR mice (n = 80) were fed with normal diet, high-fat diet (HFD), HFD supplemented with astilbin, caffeine, or astilbin + caffeine for 12 weeks. When diets supplemented with astilbin, 0.3 g kg-1 diet caffeine had the same effect as 0.6 g kg-1 diet caffeine alone, and 0.6 g kg-1 diet caffeine combined with astilbin most effectively inhibited HFD-induced obesity. Astilbin improved the anti-obesity effects of caffeine on lipid accumulation via the activation of AMP-activated protein kinase α (AMPKα). (i) Activated AMPKα decreased lipid biosynthesis by suppressing the activity or mRNA expression of 3-hydroxy-3-methylglutaryl-CoA reductase, sterol regulatory element binding protein 1c and its target gene fatty acid synthase. (ii) Activated AMPKα also up-regulated lipolysis by enhancing the expression of adipose triglyceride lipase and increasing the phosphorylation of hormone-sensitive lipase. (iii) Finally, activated AMPKα increased carnitine acyltransferase and acyl-CoA oxidase activities, which further promoted fatty acid ß-oxidation. CONCLUSION: The results obtained in the present study indicate that astilbin may decrease the effective dose of caffeine needed for an anti-obesity effect and also suggest that it suppresses fat accumulation via the activation of AMPK. © 2020 Society of Chemical Industry.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Fármacos Antiobesidad/administración & dosificación , Cafeína/administración & dosificación , Flavonoles/administración & dosificación , Metabolismo de los Lípidos/efectos de los fármacos , Obesidad/tratamiento farmacológico , Proteínas Quinasas Activadas por AMP/genética , Animales , Fármacos Antiobesidad/antagonistas & inhibidores , Cafeína/antagonistas & inhibidores , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos/análisis , Humanos , Lipogénesis/efectos de los fármacos , Lipólisis/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos ICR , Ratones Obesos , Obesidad/genética , Obesidad/metabolismo , Obesidad/fisiopatología , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/genética , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/metabolismo
2.
Food Funct ; 9(4): 2043-2050, 2018 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-29570193

RESUMEN

Stimulating the browning of white adipocytes contributes to the restriction of obesity and related metabolic disorders. This study aimed to investigate the browning effects of phytol on mice inguinal subcutaneous white adipose tissue (iWAT) and explore the underlying mechanisms. Our results demonstrated that phytol administration decreased body weight gain and iWAT index, and stimulated the browning of mice iWAT, with the increased expression of brown adipocyte marker genes (UCP1, PRDM16, PGC1α, PDH, and Cyto C). In addition, phytol treatment activated the AMPKα signaling pathway in mice iWAT. In good agreement with the in vivo findings, the in vitro results showed that 100 µM phytol stimulated brown adipogenic differentiation and formation of brown-like adipocytes in the differentiated 3T3-L1 by increasing the mitochondria content and oxygen consumption, and promoting mRNA and/or protein expression of brown adipocyte markers (UCP1, PRDM16, PGC1α, PDH, Cyto C, Cidea and Elovl3) and beige adipocyte markers (CD137 and TMEM26). Meanwhile, phytol activated the AMPKα signaling pathway in the differentiated 3T3-L1. However, the inhibition of AMPKα with Compound C totally abolished phytol-stimulated brown adipogenic differentiation and formation of brown-like adipocytes. In conclusion, these results showed that phytol stimulated the browning of mice iWAT, which was coincident with the increased formation of brown-like adipocytes in the differentiated 3T3-L1, and appeared to be primarily mediated by the AMPKα signaling pathway. These data provided new insight into the role of phytol in regulating the browning of WAT and suggested the potential application of phytol as a nutritional intervention for the restriction of obesity and related metabolic disorders.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Adipocitos Beige/metabolismo , Fármacos Antiobesidad/uso terapéutico , Suplementos Dietéticos , Obesidad/prevención & control , Fitol/uso terapéutico , Grasa Subcutánea Abdominal/metabolismo , Células 3T3-L1 , Proteínas Quinasas Activadas por AMP/antagonistas & inhibidores , Proteínas Quinasas Activadas por AMP/química , Adipocitos Beige/efectos de los fármacos , Adipocitos Beige/patología , Adipogénesis/efectos de los fármacos , Adiposidad , Animales , Fármacos Antiobesidad/antagonistas & inhibidores , Fármacos Antiobesidad/metabolismo , Biomarcadores/metabolismo , Dieta Alta en Grasa/efectos adversos , Activación Enzimática/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/etiología , Obesidad/metabolismo , Obesidad/patología , Fitol/antagonistas & inhibidores , Fitol/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Distribución Aleatoria , Transducción de Señal/efectos de los fármacos , Grasa Subcutánea Abdominal/efectos de los fármacos , Grasa Subcutánea Abdominal/patología
3.
Diabetes ; 65(5): 1410-23, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-26936964

RESUMEN

Beige adipocytes emerge postnatally within the white adipose tissue in response to certain environmental cues, such as chronic cold exposure. Because of its highly recruitable nature and relevance to adult humans, beige adipocytes have gained much attention as an attractive cellular target for antiobesity therapy. However, molecular circuits that preferentially promote beige adipocyte biogenesis remain poorly understood. We report that a combination of mild cold exposure at 17°C and capsinoids, a nonpungent analog of capsaicin, synergistically and preferentially promotes beige adipocyte biogenesis and ameliorates diet-induced obesity. Gain- and loss-of-function studies show that the combination of capsinoids and cold exposure synergistically promotes beige adipocyte development through the ß2-adrenoceptor signaling pathway. This synergistic effect on beige adipocyte biogenesis occurs through an increased half-life of PRDM16, a dominant transcriptional regulator of brown/beige adipocyte development. We document a previously unappreciated molecular circuit that controls beige adipocyte biogenesis and suggest a plausible approach to increase whole-body energy expenditure by combining dietary components and environmental cues.


Asunto(s)
Aclimatación , Adipocitos Beige/fisiología , Adipogénesis , Fármacos Antiobesidad/uso terapéutico , Capsaicina/análogos & derivados , Suplementos Dietéticos , Obesidad/prevención & control , Adipocitos Beige/citología , Adipocitos Beige/efectos de los fármacos , Adipocitos Beige/patología , Adipogénesis/efectos de los fármacos , Agonistas de Receptores Adrenérgicos beta 2/farmacología , Agonistas de Receptores Adrenérgicos beta 2/uso terapéutico , Antagonistas de Receptores Adrenérgicos beta 2/farmacología , Antagonistas de Receptores Adrenérgicos beta 2/toxicidad , Animales , Fármacos Antiobesidad/agonistas , Fármacos Antiobesidad/antagonistas & inhibidores , Capsaicina/agonistas , Capsaicina/antagonistas & inhibidores , Capsaicina/química , Capsaicina/uso terapéutico , Células Cultivadas , Frío , Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Metabolismo Energético/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Hidrogenación , Masculino , Ratones Endogámicos C57BL , Ratones Transgénicos , Obesidad/inducido químicamente , Obesidad/metabolismo , Obesidad/patología , Consumo de Oxígeno/efectos de los fármacos , Estabilidad Proteica/efectos de los fármacos , Distribución Aleatoria , Receptores Adrenérgicos beta 2/química , Receptores Adrenérgicos beta 2/genética , Receptores Adrenérgicos beta 2/metabolismo , Transducción de Señal/efectos de los fármacos , Factores de Transcripción/química , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA